collection
MENU ▼
Read by QxMD icon Read
search

Practice: EP AF

shared collection
10 papers 0 to 25 followers
https://www.readbyqxmd.com/read/24682347/2014-aha-acc-hrs-guideline-for-the-management-of-patients-with-atrial-fibrillation-a-report-of-the-american-college-of-cardiology-american-heart-association-task-force-on-practice-guidelines-and-the-heart-rhythm-society
#1
Craig T January, L Samuel Wann, Joseph S Alpert, Hugh Calkins, Joaquin E Cigarroa, Joseph C Cleveland, Jamie B Conti, Patrick T Ellinor, Michael D Ezekowitz, Michael E Field, Katherine T Murray, Ralph L Sacco, William G Stevenson, Patrick J Tchou, Cynthia M Tracy, Clyde W Yancy
No abstract text is available yet for this article.
December 2, 2014: Circulation
https://www.readbyqxmd.com/read/25421049/cardiology-patient-page-warfarin-versus-novel-oral-anticoagulants-how-to-choose
#2
REVIEW
Rishi K Wadhera, Cori E Russell, Gregory Piazza
No abstract text is available yet for this article.
November 25, 2014: Circulation
https://www.readbyqxmd.com/read/24771721/atrial-antitachycardia-pacing-and-managed-ventricular-pacing-in-bradycardia-patients-with-paroxysmal-or-persistent-atrial-tachyarrhythmias-the-minerva-randomized-multicentre-international-trial
#3
RANDOMIZED CONTROLLED TRIAL
Giuseppe Boriani, Raymond Tukkie, Antonis S Manolis, Lluis Mont, Helmut Pürerfellner, Massimo Santini, Giuseppe Inama, Paolo Serra, João de Sousa, Giovanni Luca Botto, Lorenza Mangoni, Andrea Grammatico, Luigi Padeletti
AIMS: Atrial fibrillation (AF) is a common comorbidity in bradycardia patients. Advanced pacemakers feature atrial preventive pacing and atrial antitachycardia pacing (DDDRP) and managed ventricular pacing (MVP), which minimizes unnecessary right ventricular pacing. We evaluated whether DDDRP and MVP might reduce mortality, morbidity, or progression to permanent AF when compared with standard dual-chamber pacing (Control DDDR). METHODS AND RESULTS: In a randomized, parallel, single-blind, multi-centre trial we enrolled 1300 patients with bradycardia and previous atrial tachyarrhythmias, in whom a DDDRP pacemaker had recently been implanted...
September 14, 2014: European Heart Journal
https://www.readbyqxmd.com/read/24722803/balancing-stroke-and-bleeding-risks-in-patients-with-atrial-fibrillation-and-renal-failure-the-swedish-atrial-fibrillation-cohort-study
#4
Leif Friberg, Lina Benson, Gregory Y H Lip
BACKGROUND: Patients who have both atrial fibrillation (AF) and renal failure have an increased risk of thrombo-embolism. Renal failure is also a risk factor for bleeding, which makes decisions regarding thromboprophylaxis complicated. Our aim was to determine risks for ischaemic stroke and bleeding in patients with AF and renal failure in relation to anticoagulant strategies. METHODS AND RESULTS: This is retrospective non-randomized study of Swedish health registers comprising 307 351 patients with AF, of whom 13 435 had a previous diagnosis of renal failure...
February 1, 2015: European Heart Journal
https://www.readbyqxmd.com/read/24670418/the-dialysis-procedure-as-a-trigger-for-atrial-fibrillation-new-insights-in-the-development-of-atrial-fibrillation-in-dialysis-patients
#5
RANDOMIZED CONTROLLED TRIAL
M S Buiten, M K de Bie, J I Rotmans, B A Gabreëls, W van Dorp, R Wolterbeek, S A Trines, M J Schalij, J W Jukema, T J Rabelink, L van Erven
AIMS: Atrial fibrillation (AF) is common in dialysis patients and is associated with increased morbidity and mortality. The pathophysiology may be related to common risk factors for both AF and renal disease or to dialysis-specific factors. The purpose of this study was to determine whether and how AF onset relates to the dialysis procedure itself. METHODS: All dialysis patients enrolled in the implantable cardioverter defibrillator-2 (ICD-2) trial until January 2012, who were implanted with an ICD, were included in this study...
May 2014: Heart: Official Journal of the British Cardiac Society
https://www.readbyqxmd.com/read/24650881/surgical-ablation-for-treatment-of-atrial-fibrillation-in-cardiac-surgery-a-cumulative-meta-analysis-of-randomised-controlled-trials
#6
REVIEW
Kevin Phan, Ashleigh Xie, Mark La Meir, Deborah Black, Tristan D Yan
INTRODUCTION: Concomitant surgical ablation is a treatment modality for patients with atrial fibrillation (AF) undergoing cardiac surgery, however, its efficacy and clinical outcomes are not well established. The present study is the first cumulative meta-analysis of randomised controlled trials (RCT) on clinical outcomes of surgical ablation versus no ablative treatment in all patients with cardiac surgery. METHODS: Electronic searches were performed using six databases from their inception to October 2013, identifying all relevant RCTs comparing surgical ablation versus no ablation in patients with AF undertaking cardiac surgery...
May 2014: Heart: Official Journal of the British Cardiac Society
https://www.readbyqxmd.com/read/23460057/cognitive-impairment-associated-with-atrial-fibrillation-a-meta-analysis
#7
REVIEW
Shadi Kalantarian, Theodore A Stern, Moussa Mansour, Jeremy N Ruskin
BACKGROUND: Atrial fibrillation (AF) has been linked with an increased risk for cognitive impairment and dementia. PURPOSE: To complete a meta-analysis of studies examining the association between AF and cognitive impairment. DATA SOURCES: Search of MEDLINE, PsycINFO, Cochrane Library, CINAHL, and EMBASE databases and hand search of article references. STUDY SELECTION: Prospective and nonprospective studies reporting adjusted risk estimates for the association between AF and cognitive impairment...
March 5, 2013: Annals of Internal Medicine
https://www.readbyqxmd.com/read/21870978/apixaban-versus-warfarin-in-patients-with-atrial-fibrillation
#8
RANDOMIZED CONTROLLED TRIAL
Christopher B Granger, John H Alexander, John J V McMurray, Renato D Lopes, Elaine M Hylek, Michael Hanna, Hussein R Al-Khalidi, Jack Ansell, Dan Atar, Alvaro Avezum, M Cecilia Bahit, Rafael Diaz, J Donald Easton, Justin A Ezekowitz, Greg Flaker, David Garcia, Margarida Geraldes, Bernard J Gersh, Sergey Golitsyn, Shinya Goto, Antonio G Hermosillo, Stefan H Hohnloser, John Horowitz, Puneet Mohan, Petr Jansky, Basil S Lewis, Jose Luis Lopez-Sendon, Prem Pais, Alexander Parkhomenko, Freek W A Verheugt, Jun Zhu, Lars Wallentin
BACKGROUND: Vitamin K antagonists are highly effective in preventing stroke in patients with atrial fibrillation but have several limitations. Apixaban is a novel oral direct factor Xa inhibitor that has been shown to reduce the risk of stroke in a similar population in comparison with aspirin. METHODS: In this randomized, double-blind trial, we compared apixaban (at a dose of 5 mg twice daily) with warfarin (target international normalized ratio, 2.0 to 3.0) in 18,201 patients with atrial fibrillation and at least one additional risk factor for stroke...
September 15, 2011: New England Journal of Medicine
https://www.readbyqxmd.com/read/19717844/dabigatran-versus-warfarin-in-patients-with-atrial-fibrillation
#9
RANDOMIZED CONTROLLED TRIAL
Stuart J Connolly, Michael D Ezekowitz, Salim Yusuf, John Eikelboom, Jonas Oldgren, Amit Parekh, Janice Pogue, Paul A Reilly, Ellison Themeles, Jeanne Varrone, Susan Wang, Marco Alings, Denis Xavier, Jun Zhu, Rafael Diaz, Basil S Lewis, Harald Darius, Hans-Christoph Diener, Campbell D Joyner, Lars Wallentin
BACKGROUND: Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new oral direct thrombin inhibitor. METHODS: In this noninferiority trial, we randomly assigned 18,113 patients who had atrial fibrillation and a risk of stroke to receive, in a blinded fashion, fixed doses of dabigatran--110 mg or 150 mg twice daily--or, in an unblinded fashion, adjusted-dose warfarin...
September 17, 2009: New England Journal of Medicine
https://www.readbyqxmd.com/read/18565859/rhythm-control-versus-rate-control-for-atrial-fibrillation-and-heart-failure
#10
RANDOMIZED CONTROLLED TRIAL
Denis Roy, Mario Talajic, Stanley Nattel, D George Wyse, Paul Dorian, Kerry L Lee, Martial G Bourassa, J Malcolm O Arnold, Alfred E Buxton, A John Camm, Stuart J Connolly, Marc Dubuc, Anique Ducharme, Peter G Guerra, Stefan H Hohnloser, Jean Lambert, Jean-Yves Le Heuzey, Gilles O'Hara, Ole Dyg Pedersen, Jean-Lucien Rouleau, Bramah N Singh, Lynne Warner Stevenson, William G Stevenson, Bernard Thibault, Albert L Waldo
BACKGROUND: It is common practice to restore and maintain sinus rhythm in patients with atrial fibrillation and heart failure. This approach is based in part on data indicating that atrial fibrillation is a predictor of death in patients with heart failure and suggesting that the suppression of atrial fibrillation may favorably affect the outcome. However, the benefits and risks of this approach have not been adequately studied. METHODS: We conducted a multicenter, randomized trial comparing the maintenance of sinus rhythm (rhythm control) with control of the ventricular rate (rate control) in patients with a left ventricular ejection fraction of 35% or less, symptoms of congestive heart failure, and a history of atrial fibrillation...
June 19, 2008: New England Journal of Medicine
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"